KLHL42 and synovial sarcoma: A series of specific marker genes of SCs were identified in order to facilitate the diagnosis and prognosis of MF/SS, further illustrating the KLHL42-associated pathogenesis of CTCL and providing new insight for precision-targeted CTCL therapy.